Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Payables (2018 - 2025)

Historic Payables for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $1.5 million.

  • Neurogene's Payables fell 831.35% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 831.35%. This contributed to the annual value of $1.3 million for FY2024, which is 4853.62% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Payables is $1.5 million, which was down 831.35% from $2.1 million recorded in Q2 2025.
  • Neurogene's Payables' 5-year high stood at $5.4 million during Q1 2023, with a 5-year trough of $1.3 million in Q4 2024.
  • Its 3-year average for Payables is $2.5 million, with a median of $2.1 million in 2025.
  • As far as peak fluctuations go, Neurogene's Payables crashed by 7192.4% in 2024, and later surged by 10124.84% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Payables stood at $2.6 million in 2023, then crashed by 48.54% to $1.3 million in 2024, then grew by 15.57% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $2.1 million for Q2 2025, and $3.1 million during Q1 2025.